Breast Cancer Clinical Trials

Find Breast Cancer Clinical Trials Near You

The European Organisation for Research and Treatment of Cancer: Module Development for Metastatic Breast Cancer (Phase I-IIIa/b)

Status: Recruiting
Location: See all (22) locations...
Study Type: Observational
SUMMARY

The overall aim of this project is to help improve the Health Related Quality of Life (HRQOL) of metastatic breast cancer (MBC) patients. There is currently an urgent and unmet need for specific tools to aid in the evaluation of HRQOL in MBC and this project aims to address these needs by developing a comprehensive EORTC questionnaire for assessing the HRQOL of this group. The new module will be used in conjunction with EORTC QLQ-C30 and will provide better measurement of the quality of life issues experienced by women with MBC. Interviews will be conducted with patients from several centres across Europe, guiding the development process in a patient centred way.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
View:

• Adult females aged 18 years or over.

• Have a diagnosis of MBC (Breast cancer that has spread to another part of the body), including de novo MBC patients. Patients with brain metastases will be included, providing there is no associated major cognitive impairment.

• Have received (patients under observation) or currently receiving treatment for MBC, including chemotherapy, hormone therapy, targeted agents (anti-HER2, CDK4/6 inhibitors, mTOR/PIK3CA inhibitors, PARP inhibitors, immune therapy), radiotherapy and combinations.

• Conversant in the language of questionnaire administration.

• Have the capacity to give informed consent.

Locations
Other Locations
Belgium
Ghent University Hospital
NOT_YET_RECRUITING
Ghent
Canada
Centre hospitalier de l'Université de Montreal
NOT_YET_RECRUITING
Montreal
Odette Cancer Center - Sunnybrook Health Sciences Center
RECRUITING
Toronto
France
Centre Hospitalier Lyon Sud
RECRUITING
Lyon
University Hospital of Nimes
NOT_YET_RECRUITING
Nîmes
Centre Hospitalier Universitaire de Saint-Etienne
NOT_YET_RECRUITING
Saint-etienne
Germany
Charité - Universitätsmedizin
NOT_YET_RECRUITING
Berlin
Helios University Hospital
RECRUITING
Wuppertal
India
Tata Memorial Hospital
NOT_YET_RECRUITING
Mumbai
Italy
Istituto Nazionale Tumori
RECRUITING
Naples
Veneto Institute of Oncology
NOT_YET_RECRUITING
Padova
Japan
Kansai Medical University Hospital
RECRUITING
Osaka
National Cancer Centre Hospital
RECRUITING
Tokyo
National Centre for Global Health and Medicine
RECRUITING
Tokyo
Jordan
King Hussein Cancer Center
RECRUITING
Amman
Netherlands
NKI-AVL Amsterdam
RECRUITING
Amsterdam
Poland
Maria Sklodowska Curie National Research Institute of Oncology
NOT_YET_RECRUITING
Warsaw
Portugal
Champalimaud Clinical Centre
NOT_YET_RECRUITING
Lisbon
Slovakia
Comenius University and National Cancer Institute
NOT_YET_RECRUITING
Bratislava
Spain
Royal Navarre Hospital
RECRUITING
Pamplona
United Kingdom
St James University hospital
RECRUITING
Leeds
Mount Vernon Cancer Centre
RECRUITING
Rickmansworth
Time Frame
Start Date: 2020-05-01
Estimated Completion Date: 2029-05-31
Participants
Target number of participants: 568
Related Therapeutic Areas
Sponsors
Leads: University of Leeds

This content was sourced from clinicaltrials.gov